An Age Old Problem? Estimating the Impact of Dementia on Past Human Populations

Journal of Aging and Health
Martin SmithClare Cutler

Abstract

To model the impact of dementia on past societies. We consider multiple lines of evidence indicating elderly individuals to have been more common throughout the past than is frequently accepted. We then apply known dementia incidence/prevalence rates to plausible assumptions of past population structures to suggest prevalence in the past. Dementia prevalence in premodern societies is likely to have been around 5% of the rate seen in modern, developed countries but with a total past incidence running into billions. Dementia is often seen as a "modern" challenge that humans have not had to contend with before. We argue that this condition has had considerably greater effects than previously envisaged and is a challenge that humans have already withstood successfully, on one hand at a lower incidence but on the other without the considerable clinical, technological, and social advances that have been made in recent times.

References

Feb 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·B J Gaffney
Nov 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·R G Cutler
Aug 1, 1992·International Journal of Epidemiology·K RitchieJ M Robine
Nov 1, 1989·American Journal of Physical Anthropology·D N Dickel, G H Doran
Jan 1, 1982·American Journal of Physical Anthropology·E Trinkaus, M R Zimmerman
Jan 1, 1974·European Demographic Information Bulletin·P Weintraub
Oct 10, 2002·Neurology·Martha StorandtJohn C Morris
Dec 20, 2005·Lancet·Cleusa P FerriUNKNOWN Alzheimer's Disease International
Jan 27, 2006·The Journal of the Association of Nurses in AIDS Care : JANAC·Edythe S HoughHesham F Gadelrab
Jan 31, 2006·Journal of the Neurological Sciences·Axel Karenberg, Hans Förstl
Oct 10, 2007·Veterinary Research Communications·M L Bacci
Jan 12, 2008·BMJ : British Medical Journal·Jing XieUNKNOWN Medical Research Council Cognitive Function and Ageing Study collaborators
Mar 20, 2008·Age and Ageing·Claudia CooperGill Livingston
Aug 1, 2008·Lancet Neurology·Raj N KalariaUNKNOWN World Federation of Neurology Dementia Research Group
Jul 1, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Ron BrookmeyerH Michael Arrighi
Jan 1, 2007·Indian Journal of Psychiatry·Somasundaram Ottilingam
Aug 10, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Elizabeth ColantuoniRon Brookmeyer
Oct 12, 2010·The Australian and New Zealand Journal of Psychiatry·Scott Henderson, G A Broe
Oct 12, 2010·The Australian and New Zealand Journal of Psychiatry·Kate SmithDina LoGiudice
Jan 25, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Ron BrookmeyerWalter A Kukull
Jan 25, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Walter A RoccaLon R White
Aug 1, 2012·Scandinavian Journal of Caring Sciences·Patrik RytterströmMitra Unosson
Aug 11, 2012·Journal of the Neurological Sciences·Joseree-Ann S CatindigChristopher Chen
Oct 23, 2012·Archives of Medical Research·Sube Banerjee
Dec 1, 2009·International Health·Eric Midwinter
Mar 1, 2011·International Journal of Paleopathology·Lorna Tilley, Marc F Oxenham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.